The precautions for the use of Lucetine Capsule (Fluoxetine Hydrochloride) have been changed in accordance with the instructions for change in drug manufacturing (import) product approval from the Food and Drug Safety Administration (Drug Management Team No. 6629, effective date 2007. 05. 16).
For further details, please refer to the ‘Product Introduction’ section and attached documents.
Lucetin Cap.
Attachments are original documents and may be in Korean. English editions are labeled separately.
Lucetin Capsule 2.hwpLucetin capsule (precautions for use) change (2007.05.16).hwp · 36 KBDownload ↓